Evidence map›Paper›PMID 28731440›Full record

ArticleJournal of Alzheimer's disease : JAD2017

Challenges and Considerations Related to Studying Dementia in Blacks/African Americans.

Eseosa T Ighodaro, Peter T Nelson, Walter A Kukull, Frederick A Schmitt, Erin L Abner, Allison Caban-Holt, Shoshana H Bardach, Derrick C Hord, Crystal M Glover, Gregory A Jicha and 3 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Development and Preliminary Validation of Standardized Regression-Based Change Scores as Measures of Transitional Cognitive Decline.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Article
  3. ARTS is associated with vascular risk factors, MCI, dementia, and stroke.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  6. Cerebral arteriolosclerosis, lacunar infarcts, and cognition in older Black adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Eseosa T IghodaroDepartment of Neuroscience, University of Kentucky, Lexington, KY, USA.
Peter T NelsonDepartment of Neuroscience, University of Kentucky, Lexington, KY, USA.
Walter A KukullNational Alzheimer's Coordinating Center, Department of Epidemiology, University of Washington, Seattle, WA, USA.
Frederick A SchmittSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Erin L AbnerSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Allison Caban-HoltSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Shoshana H BardachSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Derrick C HordSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Crystal M GloverRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Gregory A JichaSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Linda J Van EldikDepartment of Neuroscience, University of Kentucky, Lexington, KY, USA.
Alexander X ByrdDepartment of History, Rice University, Houston, Texas, USA.
Anita FernanderDepartment of Behavioral Science, University of Kentucky, Lexington, KY, USA.
University of Kentucky · USRice University · USRush University Medical Center · USThe Graduate Center, CUNY · USUniversity of Washington · US

Funding

NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI GOLD, BRIAN TIMOTHY, VAN ELDIK, LINDA J · 2006 to 2020
$23.3M
Role of impaired cognitive states & risk factors in conversion to mixed dementiasR01AG038651 · NIA · UNIVERSITY OF KENTUCKY · PI ABNER, ERIN, KRYSCIO, RICHARD J. · 2011 to 2023
$6.1M
THE MOLECULAR AND CELLULAR BASIS OF BRAIN AGINGT32AG000242 · NIA · UNIVERSITY OF KENTUCKY · PI GERHARDT, GREG A. · 1994 to 2013
$3.4M
Novel pathogenetic mechanism for hippocampal sclerosis, a common Alzheimers mimicR01AG057187 · NIA · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2017 to 2021
$2.2M
INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression: The INCREASE studyR01AG054130 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, MOGA, DANIELA CLAUDIA · 2016 to 2020
$2.0M
Early Detection and Prevention of Mild Cognitive Impairment due to Cerebrovascular DiseaseR01NR014189 · NINR · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, MOSER, DEBRA KAY · 2012 to 2016
$2.0M
Modulation of microRNA pathways by gemfibrozil in predementia Alzheimer diseaseR01AG042419 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, NELSON, PETER T. · 2013 to 2016
$1.6M
CELLULAR CHANGES ALTERING SYNAPTIC CONNECTIVITY IN PRECLINICAL ADR01AG042475 · NIA · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2013 to 2017
$1.5M
Statistical Genetics Methods for Mixed PathologiesK25AG043546 · NIA · UNIVERSITY OF KENTUCKY · PI FARDO, DAVID WILLIAM · 2013 to 2015
$445k
NIA NIH HHS K25 AG043546NIA NIH HHS P30 AG028383NIA NIH HHS R01 AG038651NIA NIH HHS R01 AG042419NIA NIH HHS R01 AG042475NIA NIH HHS R01 AG054130NIA NIH HHS R01 AG057187NIA NIH HHS U01 AG016976NINR NIH HHS R01 NR014189
6 · The paper itself

Abstract

Blacks/African Americans have been reported to be ∼2-4 times more likely to develop clinical Alzheimer's disease (AD) compared to Whites. Unfortunately, study design challenges (e.g., recruitment bias), racism, mistrust of healthcare providers and biomedical researchers, confounders related to socioeconomic status, and other sources of bias are often ignored when interpreting differences in human subjects categorized by race. Failure to account for these factors can lead to misinterpretation of results, reification of race as biology, discrimination, and missed or delayed diagnoses. Here we provide a selected historical background, discuss challenges, present opportunities, and suggest considerations for studying health outcomes among racial/ethnic groups. We encourage neuroscientists to consider shifting away from using biologic determination to interpret data, and work instead toward a paradigm of incorporating both biological and socio-environmental factors known to affect health outcomes with the goal of understanding and improving dementia treatments for Blacks/African Americans and other underserved populations.

Indexed as

RacismTrustAttitude to HealthBiomedical ResearchBlack or African AmericanDementiaEthnicityHumansResearch SubjectsUnited StatesAutopsyepidemiologyethnicityneurodegenerativeneuropathology

Identifiers

PMID28731440
PMCPMC5889715
OpenAlexW2737266618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.